Health Care Up as Improved Risk Appetite Buoys Biotech -- Health Care Roundup

Features Dow Jones Newswires

Shares of health-care companies rose as a recovery in risk appetite supported biotech stocks. Officials in the United Kingdom said the National Health Service plans to distribute generic versions of Gilead's Truvada HIV drug in a clinical trial to avoid infringing the biotech company's patent protection.

Continue Reading Below

--Rob Curran, rob.curran@dowjones.com

(END) Dow Jones Newswires

August 11, 2017 16:23 ET (20:23 GMT)